Hematology
Guidelines
Updated AHA/ASA guideline changes care for spontaneous intracerebral hemorrhage
Several “standard care” therapies for ICH are not as effective as once thought and are no longer recommended in updated guidelines.
From the Journals
Cancer patients unaware of their increased thrombosis risk
“These professionals are on the front line of the battle; they are among the first healthcare workers given the chance to suspect a clot and...
Conference Coverage
Novel COVID-19 vaccine could fill the void for patients with blood cancers
Existing vaccines provide weak protection for immunocompromised patients with B-cell deficiencies.
Feature
Rare pediatric cancers persist 63 years after nuclear accident
Near Los Angeles, the parents of kids whose cluster of rare leukemias and other cancers may be linked to a 1959 partial meltdown at Santa Susana...
Latest News
Complex link between gut microbiome and immunotherapy response in advanced melanoma
Previous studies have identified the gut microbiome as “a potential biomarker of response as well as a therapeutic target” in melanoma and other...
From the Journals
More exercise for people with hemophilia, experts advise
Physical activity can improve “quality of life” in people with hemophilia.
From the Journals
Post–COVID vaccine AHA cases raise eyebrows in Italy
Four cases of acquired hemophilia A that occurred following COVID-19 vaccinations in one Italian province could indicate “possible complications...
From the Journals
Endometriosis not linked with preterm birth, new study finds
Changing monitoring strategies to prevent preterm birth for women with the disease may not be necessary.
From the Journals
Stopping venetoclax treatment early reduces CLL survival outcomes
Survival outcomes are decreased with early, permanent discontinuation of venetoclax but unchanged by treatment interruption, regardless of...
Latest News
Prophylactic meds may prevent cesarean bleeding
“As methylergonovine is a known contraindication to hypertensive and cardiovascular disorders, patients would have to be carefully screened.”
News
FDA approves first-ever drug for cold agglutinin disease
The first drug to treat a rare anemia has been given the green light by the FDA.